Chinese medicine exports light up the downturn in the foreign trade market


Release time:

2014-12-29


In the first half of 2014, affected by the continued low-speed growth during the transition period of the world economy, the growth rate of my country's traditional Chinese medicine foreign trade dropped from the first quarter, with imports and exports of US $2.194 billion billion, an increase of 10.76 year-on-year. Among them, exports were 1.691 billion US dollars, up 13.41 per cent year-on-year. Imports were 0.503 billion US dollars, up 2.67 per cent year-on-year. Excluding the import value of extracts decreased by 23.1 year on year, the import and export value of other products increased by different ranges.
Import and export panorama
Traditional market recovery
Affected by the steady recovery trend of the market, especially the traditional market, in the first half of this year, China's export volume of extract products increased by 21.2, reaching 0.84 billion billion US dollars. Stevia extract, blueberry extract and licorice extract and other advantageous varieties of export volume still maintained a substantial growth, becoming a hot product on the export list.
In the first half of 2014, China's traditional Chinese medicine was exported to 158 countries and regions, and Asia is still the main market for traditional Chinese medicine exports. China's exports of traditional Chinese medicine to Asian countries and regions reached 1.063 billion billion US dollars, an increase of 15.45 percent over the same period last year, accounting for 62.89 percent of China's traditional Chinese medicine exports. Among them, Hong Kong, Japan, South Korea and ASEAN countries are the main target markets. Hong Kong, China has become the first market for Chinese medicine exports, with exports of US $0.316 billion billion and maintaining a steady growth of 5%. It is worth noting that the export of traditional Chinese medicine to Japan rebounded in the first half of the year, changing the trend of sharp decline last year. The export value in the first half of the year was 0.265 billion billion US dollars, achieving a 25.21 per cent growth.
Import trend slows
In the first half of 2014, imports of traditional Chinese medicine products were US $0.503 billion billion, an increase of 2.67 percent year-on-year, which was significantly slower than the 23.68 percent increase in 2013.
Among them, imports of Chinese medicinal materials and decoction pieces were US $0.106 billion, a year-on-year increase of 40.81 percent, imports of health care products were US $88 million, a year-on-year increase of 3.98 percent, imports of proprietary Chinese medicines were US $0.162 billion, a year-on-year increase of 16.18 percent, and imports of extracts were US $0.146 billion, a year-on-year decrease of 23.1 percent. Chinese patent medicine is the only product in the category of traditional Chinese medicine that has maintained an increase in both the quantity and price of imports, mainly from Hong Kong, China, accounting for 58.1 per cent of total imports.
In terms of imports, except for proprietary Chinese medicines, which maintained a 12.02 per cent year-on-year growth, health products, extracts and Chinese herbal medicines and decoction pieces all showed a sharp decline, but as the prices of health products and Chinese herbal medicines and decoction pieces increased by 97.7 per cent and 79.7 per cent respectively compared with the same period last year, the import volume of these two types of products still maintained a growth trend. On the contrary, imported extracts have fallen both in volume and price. In the first half of this year, my country imported 11100 tons of extracts, a year-on-year decrease of 20.19. At the same time, import prices fell by 3.65 year-on-year, resulting in a year-on-year decline in the amount of imported extracts. Big.
Perspective of each commodity
The export price of herbal pieces rose and the volume fell.
Affected by the rising prices of Chinese medicinal materials in the domestic market, the prices of Chinese medicinal materials and decoction pieces exported to China are also rising. In the first half of this year, China exported 90000 tons of Chinese medicinal materials and decoction pieces, a year-on-year decrease of 10.75 percent, and the average export price rose by 20.15 percent. As a result, the export value of Chinese medicinal materials and decoction pieces in the first half of this year rose by 7.22 percent year-on-year to 0.59 billion billion US dollars.
As the first and second largest market for the export of Chinese medicinal materials and decoction pieces, the number of Chinese medicinal materials and decoction pieces purchased by Hong Kong and Japan from my country has dropped, but the prices have maintained a large increase. In the first half of this year, the mainland exported 36000 tons of Chinese medicinal materials and decoction pieces to Hong Kong, a year-on-year decrease of 22.15 percent, and the price rose by 31.54 percent year-on-year. The export value increased by 2.4 percent year-on-year to US $0.225 billion billion. my country exported 9784 tons of Chinese medicinal materials and decoction pieces to Japan, a year-on-year decrease of 2.88 percent, export prices rose by 30.1 percent year-on-year, and exports reached 0.127 billion billion U.S. dollars, achieving a relatively high growth rate of 26.35 percent.
It is worth noting that in the first half of this year, the export volume and export value of Chinese medicinal materials and decoction pieces to ASEAN showed a sharp decline, with the decline rates reaching 11.3 and 7.6 respectively. In addition, my country's exports of Chinese medicinal materials and decoction pieces to the Netherlands have grown rapidly. The export volume reached 1307 tons, a year-on-year increase of 115 percent, and the export volume was 13.3 million billion U.S. dollars, a year-on-year increase of 104.7 percent.
In the first half of this year, the export price of ginseng rose further, with a year-on-year increase of 107.43, and the export volume dropped significantly, with a year-on-year decrease of more than 30%.
Extract exports maintain good growth
In recent years, extracts accounted for an increasing proportion of China's exports of traditional Chinese medicine. In the first half of this year, China exported a total of 0.841 billion US dollars of extract products, an increase of 21.2 per cent over the same period last year, accounting for 49.75 per cent of China's exports of traditional Chinese medicine products.
In the traditional market, the United States and Japan are still the main exporters of extracts. China's exports to the United States and Japan are 0.17 billion US dollars and 0.121 billion US dollars respectively, up 11.54 per cent and 28.53 per cent year-on-year, accounting for 20.12 per cent and 14.33 per cent of exports respectively.
China's exports of extracts to ASEAN countries grew rapidly, with exports increasing by 60.8 percent year-on-year, especially to Singapore and Indonesia, with exports reaching $25.25 million and $55.81 million, respectively, and increasing by 165 percent and 101.25 percent, respectively.
Exports of patent medicines to Europe continue to decline
Europe is the largest plant medicine market in the world, and it is also one of the main target markets for the export of Chinese patent medicines in China. However, since the implementation of the EU Traditional Medicine Registration Procedure Directive (Directive 2004/24/EC), China's export of Chinese patent medicines to the EU has been severely restricted. Since May 1 this year, the UK has banned the sale of all unregistered traditional drugs in the country, further restricting the development of proprietary Chinese medicines in the EU. In the first half of this year, the export of proprietary Chinese medicines to the European Union continued to decline, with exports of only US $4.46 million, down 20.86 per cent from the same period last year. Among them, the Netherlands and Hungary are the top two markets for my country's exports to the EU. China's exports of Chinese patent medicines to the above two countries accounted for 21.74 and 17.6 respectively.
Expected >>>
The second half of the positive
In the first half of 2014, my country's foreign trade growth rate was -0.9%, which is a rare phenomenon for many years. The growth rate of pharmaceutical imports and exports was 5.4%, which has also dropped to a relatively low level. However, imports and exports of traditional Chinese medicine remained in double digits, up 13.4 per cent. It can be said that gratifying achievements have been made in the difficult foreign trade situation. In the second half of the year, with the support of several good news, China's foreign trade situation of traditional Chinese medicine products will continue to grow steadily, higher than the average growth rate of pharmaceutical foreign trade.
Extract standards continue to increase
As a major export category of traditional Chinese medicine products, the lack of plant extract standards has not only been widely criticized, but also severely restricted the healthy and vigorous development of the industry. The first batch of international business standards for plant extracts issued by the China Medical Insurance Chamber of Commerce in September last year further improved the plant extract quality standard system, filled the gaps in domestic plant extract standards, and further regulated the market order, improved the industry access mechanism, and strengthened The self-discipline of industry enterprises has played an important role.
In the second half of this year, the Chamber of Commerce will sign an agreement with the United States Pharmacopoeia Commission to jointly formulate plant extract standards and prepare and edit the "Plant Extract Monographs" recognized by both parties to further regulate the international trade of plant extracts. The standards to be formulated in the second half of the year are: green tea extract, citrus young fruit extract (hesperidin), green coffee bean extract, grape seed extract, epimedium extract, white peony extract, rutin, fucoidan, ganoderma lucidum extract, pueraria extract, etc.
Extract Customs Code Manual to be Launched
In recent years, the controversial classification of plant extracts by customs codes has become an important obstacle to import and export trade. In the second half of the year, the Chamber of Commerce and the General Administration of Customs will jointly compile the "Plant Extract Customs Code Classification Manual", which covers 265 bulk plant extract export products and is expected to be published in June next year. The manual will become a product code classification tool jointly recognized by local customs and plant extract export enterprises, and the probability of misjudgment of export code classification will be further reduced, creating a level playing field for export enterprises.
Health care products approval filing system or combination
On July 2, the Ninth Session of the Twelfth National People's Congress formally completed the initial review of the "the People's Republic of China Food Safety Law (Revised Draft)" (hereinafter referred to as the revised draft), and formally solicited opinions from the society. In the revised draft, the implementation of the filing system is mentioned for the first time for the registration of health food, which means that the examination and approval system for health products stipulated in the measures for the Administration of Health Food Registration (trial), which has been tried out since 2005, is expected to change. As a result, the health food market may usher in more competitors, especially good imported health products. However, the lack of prior testing may lead to more health food safety problems. This requires enterprises to have a higher industry self-discipline, but also calls for effective market supervision. One thing is certain, this move will activate the entire large health market, may change the entire pattern of the domestic health care products industry, the future health care products market is expected to usher in more foreign participants.